| Literature DB >> 33451061 |
Isabel González-Alvarez1, Verónica Vivancos1, Carmen Coll2,3,4,5, Bárbara Sánchez-Dengra1, Elena Aznar2,3, Alejandro Ruiz-Picazo1, Marival Bermejo1, Félix Sancenón2,3,4,5, María Auxiliadora Dea-Ayuela6, Marta Gonzalez-Alvarez1, Ramón Martínez-Máñez2,3,4,5.
Abstract
Giardiasis is a parasitism produced by the protozoa Giardia intestinalis that lives as trophozoite in the small intestine (mainly in the duodenum) attached to the intestinal villus by means of billed discs. The first line treatment is metronidazole, a drug with high bioavailability, which is why to obtain therapeutic concentrations in duodenum, it is necessary to administer high doses of drug to patients with the consequent occurrence of side effects. It is necessary to developed new therapeutical approaches to achieve a local delivery of the drug. In this sense, we have developed gated mesoporous silica microparticles loaded with metronidazole and with a molecular gate pH dependent. In vitro assays demonstrated that the metronidazole release is practically insignificant at acidic pHs, but in duodenum conditions, the metronidazole delivery from the microparticles is effective enough to produce an important parasite destruction. In vivo assays indicate that this microparticulate system allows to increase the concentration of the drug in duodenum and reduce the concentration in plasma avoiding systemic effects. This system could be useful for other intestinal local treatments in order to reduce doses and increase drug availability in target tissues.Entities:
Keywords: G. intestinalis; mesoporous microparticles; molecular gate; oral administration; targeted drug delivery
Year: 2021 PMID: 33451061 PMCID: PMC7828499 DOI: 10.3390/pharmaceutics13010094
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321